{"id":6776,"date":"2022-12-15T10:06:00","date_gmt":"2022-12-15T05:06:00","guid":{"rendered":"https:\/\/www.serenepharma.com\/?p=6776"},"modified":"2023-02-07T10:08:02","modified_gmt":"2023-02-07T05:08:02","slug":"jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi","status":"publish","type":"post","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/","title":{"rendered":"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi"},"content":{"rendered":"\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Tanishuv<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">2-tip qandli diabet bilan og&#8217;rigan bemorlar (2TQD) alkogolsiz yog&#8217;li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og&#8217;rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So&#8217;nggi tadqiqotlar T2DM bilan og&#8217;rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta&#8217;sirini ko&#8217;rsatdi.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Maqsadlar<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Empagliflozinning AYJK bilan bog&#8217;liq steatoz va fibroz keltirib chiqarish xavfiga ta&#8217;sirini baholash<\/li><li>EMPA-REG NATIJASI sinovida xavf kategoriyalari va kariorenal oqibatlari natijalari o&#8217;rtasidagi bog&#8217;liqlikni aniqlash<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Natijalar<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>DSI va HIS bo\u2019yicha dastlabki bosqichda 73% va 84% dan va yuqori steatoz xavfi bor edi; va 23% va 4% NFS va FIB-4 tomonidan progressiv fibroz xavfi yuqori edi.<\/li><li>Empagliflozin bilan davolangan bemorlar orasida yuqori steatoz xavfi ostida bo&#8217;lgan bemorlarning ulushi biroz kamaygan, ammo placebo bilan davolanganlar orasida kamaymagan (1-jadval).<\/li><li>Empagliflozin davolash, placebo bilan solishtirganda, vaqt o&#8217;tishi bilan yuqori fibroz xavfi bo&#8217;lgan bemorlarning ulushini yaxshilamadi.<\/li><li>Placebo bilan taqqoslaganda, barcha steatoz va fibroz xavfi guruhlarida empagliflozin tana vaznini kamaytirdi.<\/li><li>Fibroz xavfining NFS va FIB-4 stratifikatsiyasiga ko&#8217;ra, zamonaviy fibroz xavfi yuqori bo&#8217;lgan bemorlarda yurak-qon tomir kasalliklaridan o&#8217;lim, birinchi navbatda yurak yetishmovchiligi (YY) tufayli kasalxonaga yotqizish, yuqori fibroz xavfi past bo&#8217;lgan tegishli guruhlarga qaraganda YY yoki yurak-qon tomir kasalliklaridan o&#8217;lim va barcha sabablarga ko&#8217;ra o&#8217;lim holatlari ancha yuqori bo&#8217;lgan.<\/li><li>Empagliflozinning yurak-tomir va barcha sabablarga ko\u02bbra o\u02bblim natijalariga ta\u02bcsiri barcha xavf guruhlari bo\u02bbyicha barqarorligicha qoldi.<\/li><\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><a href=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1-1024x622.jpg\" alt=\"\" class=\"wp-image-6777\" width=\"499\" height=\"303\" srcset=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1-1024x622.jpg 1024w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1-300x182.jpg 300w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1-768x466.jpg 768w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1-600x364.jpg 600w, https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1.jpg 1354w\" sizes=\"(max-width: 499px) 100vw, 499px\" \/><\/a><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>Xulosalar<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Empagliflozin bilan davolash steatozni yaxshilashi mumkin, ammo 2TQD va oldindan YQTK mavjud bo&#8217;lgan bemorlarda fibroz xavfini yaxshilamaydi.<\/li><li>Fibrozning yuqori xavfli <strong>yurak-qon tomir <\/strong>hodisalarining ko&#8217;payishi bilan bog&#8217;liq edi<\/li><li>Empagliflozin bilan davolash steatoz va fibroz xavfidan tashqari holda kardiorenal asoratlari va o&#8217;lim darajasining pasayishi bilan bog&#8217;liq bo\u2019lib chiqdi.<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og&#8217;rigan bemorlar (2TQD) alkogolsiz yog&#8217;li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og&#8217;rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So&#8217;nggi tadqiqotlar T2DM bilan og&#8217;rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta&#8217;sirini&#8230;<\/p>\n","protected":false},"author":1,"featured_media":6779,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","inline_featured_image":false,"footnotes":""},"categories":[141],"tags":[176],"class_list":["post-6776","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gazetauz","tag-endokrinologiya"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og&#039;rigan bemorlar (2TQD) alkogolsiz yog&#039;li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og&#039;rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So&#039;nggi tadqiqotlar T2DM bilan og&#039;rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta&#039;sirini\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"serene_admin\"\/>\n\t<meta name=\"google-site-verification\" content=\"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY\" \/>\n\t<meta name=\"yandex-verification\" content=\"4d7ed8a4cfca7240\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"uz_UZ\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Serene - The Leading Pharmaceutical Company in Central Asia\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Jigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi - Serene\" \/>\n\t\t<meta property=\"og:description\" content=\"Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og&#039;rigan bemorlar (2TQD) alkogolsiz yog&#039;li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og&#039;rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So&#039;nggi tadqiqotlar T2DM bilan og&#039;rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta&#039;sirini\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"83\" \/>\n\t\t<meta property=\"og:image:height\" content=\"80\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-12-15T05:06:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-02-07T05:08:02+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Serenepharma\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Jigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi - Serene\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og&#039;rigan bemorlar (2TQD) alkogolsiz yog&#039;li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og&#039;rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So&#039;nggi tadqiqotlar T2DM bilan og&#039;rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta&#039;sirini\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#blogposting\",\"name\":\"Jigar steatozi va fibroz belgilariga empagliflozinning ta\\u2019siri va ularning yurak-tomir natijalari bilan bog\\u2019liqligi - Serene\",\"headline\":\"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi\",\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/6uz1.jpg\",\"width\":1354,\"height\":822},\"datePublished\":\"2022-12-15T10:06:00+05:00\",\"dateModified\":\"2023-02-07T10:08:02+05:00\",\"inLanguage\":\"uz-UZ\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#webpage\"},\"articleSection\":\"Gazeta, Endokrinologiya, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"position\":2,\"name\":\"Gazeta\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#listItem\",\"name\":\"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#listItem\",\"position\":3,\"name\":\"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"telephone\":\"+998782910140\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/logo-.png\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#organizationLogo\",\"width\":286,\"height\":120},\"image\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Serenepharma\\\/\",\"https:\\\/\\\/www.instagram.com\\\/serene_group_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/\",\"name\":\"serene_admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"serene_admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#webpage\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/\",\"name\":\"Jigar steatozi va fibroz belgilariga empagliflozinning ta\\u2019siri va ularning yurak-tomir natijalari bilan bog\\u2019liqligi - Serene\",\"description\":\"Manba: Diabet Obes Metab.2022;24:1061\\u20131071, DOI: 10.1111\\\/dom.14670 Tanishuv 2-tip qandli diabet bilan og'rigan bemorlar (2TQD) alkogolsiz yog'li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og'rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So'nggi tadqiqotlar T2DM bilan og'rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta'sirini\",\"inLanguage\":\"uz-UZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/6uz1.jpg\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#mainImage\",\"width\":1354,\"height\":822},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\\\/#mainImage\"},\"datePublished\":\"2022-12-15T10:06:00+05:00\",\"dateModified\":\"2023-02-07T10:08:02+05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"inLanguage\":\"uz-UZ\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Jigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi - Serene","description":"Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og'rigan bemorlar (2TQD) alkogolsiz yog'li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og'rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So'nggi tadqiqotlar T2DM bilan og'rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta'sirini","canonical_url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY","yandex-verification":"4d7ed8a4cfca7240","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#blogposting","name":"Jigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi - Serene","headline":"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi","author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1.jpg","width":1354,"height":822},"datePublished":"2022-12-15T10:06:00+05:00","dateModified":"2023-02-07T10:08:02+05:00","inLanguage":"uz-UZ","mainEntityOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#webpage"},"isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#webpage"},"articleSection":"Gazeta, Endokrinologiya, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","position":1,"name":"Home","item":"https:\/\/www.serenepharma.com\/uz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","position":2,"name":"Gazeta","item":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#listItem","name":"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#listItem","position":3,"name":"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi","previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}}]},{"@type":"Organization","@id":"https:\/\/www.serenepharma.com\/uz\/#organization","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","url":"https:\/\/www.serenepharma.com\/uz\/","telephone":"+998782910140","logo":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/logo-.png","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#organizationLogo","width":286,"height":120},"image":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/Serenepharma\/","https:\/\/www.instagram.com\/serene_group_\/"]},{"@type":"Person","@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author","url":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/","name":"serene_admin","image":{"@type":"ImageObject","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g","width":96,"height":96,"caption":"serene_admin"}},{"@type":"WebPage","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#webpage","url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/","name":"Jigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi - Serene","description":"Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og'rigan bemorlar (2TQD) alkogolsiz yog'li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og'rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So'nggi tadqiqotlar T2DM bilan og'rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta'sirini","inLanguage":"uz-UZ","isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/#website"},"breadcrumb":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#breadcrumblist"},"author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"creator":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/6uz1.jpg","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#mainImage","width":1354,"height":822},"primaryImageOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/#mainImage"},"datePublished":"2022-12-15T10:06:00+05:00","dateModified":"2023-02-07T10:08:02+05:00"},{"@type":"WebSite","@id":"https:\/\/www.serenepharma.com\/uz\/#website","url":"https:\/\/www.serenepharma.com\/uz\/","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","inLanguage":"uz-UZ","publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"}}]},"og:locale":"uz_UZ","og:site_name":"Serene - The Leading Pharmaceutical Company in Central Asia","og:type":"article","og:title":"Jigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi - Serene","og:description":"Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og'rigan bemorlar (2TQD) alkogolsiz yog'li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og'rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So'nggi tadqiqotlar T2DM bilan og'rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta'sirini","og:url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/","og:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:secure_url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:width":83,"og:image:height":80,"article:published_time":"2022-12-15T05:06:00+00:00","article:modified_time":"2023-02-07T05:08:02+00:00","article:publisher":"https:\/\/www.facebook.com\/Serenepharma\/","twitter:card":"summary","twitter:title":"Jigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi - Serene","twitter:description":"Manba: Diabet Obes Metab.2022;24:1061\u20131071, DOI: 10.1111\/dom.14670 Tanishuv 2-tip qandli diabet bilan og'rigan bemorlar (2TQD) alkogolsiz yog'li jigar kasalligini (AYJK) rivojlantirishga moyil. AYJK bilan og'rigan deyarli 20% bemorlarda gepatik fibroz mavjud, bu esa o\u2019lim xavfini kuchli bashoratchi belgisi hisoblanadi. So'nggi tadqiqotlar T2DM bilan og'rigan bemorlarda empagliflozin bilan davolashning steatoz va jigar fibroziga foydali va ijobiy ta'sirini","twitter:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png"},"aioseo_meta_data":{"post_id":"6776","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-02-11 16:41:30","updated":"2026-02-11 16:41:30","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/\" title=\"Gazeta\">Gazeta<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tJigar steatozi va fibroz belgilariga empagliflozinning ta\u2019siri va ularning yurak-tomir natijalari bilan bog\u2019liqligi\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.serenepharma.com\/uz\/"},{"label":"Gazeta","link":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/"},{"label":"Jigar steatozi va fibroz belgilariga empagliflozinning ta&#8217;siri va ularning yurak-tomir natijalari bilan bog&#8217;liqligi","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/jigar-steatozi-va-fibroz-belgilariga-empagliflozinning-tasiri-va-ularning-yurak-tomir-natijalari-bilan-bogliqligi\/"}],"_links":{"self":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/comments?post=6776"}],"version-history":[{"count":0,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6776\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media\/6779"}],"wp:attachment":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media?parent=6776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/categories?post=6776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/tags?post=6776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}